Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

This study has been completed.
Sponsor:
Collaborators:
Northern Sydney and Central Coast Area Health Service
Aventis Pharmaceuticals
Information provided by:
Progen Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00268593
First received: December 20, 2005
Last updated: June 13, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)